OMRIX Biopharmaceuticals Receives FDA Approval For General Hemostasis In Surgery Indication For EVICEL Liquid Fibrin ... (Medical News Today)
OMRIX Biopharmaceuticals, Inc. ("OMRIX" or the "Company") (NASDAQ: OMRI) announced that the U.S. Food and Drug Administration has granted an expanded indication for general hemostasis in surgery for EVICEL Liquid Fibrin Sealant (Human).

Pennington Biomedical Research Institute Receives FDA Approval To Begin Phase I Studies Of Compellis Pharmaceuticals' ... (Medical News Today)
Compellis Pharmaceuticals, an early stage biopharmaceutical company developing novel mechanism-based therapeutics for the treatment of obesity, announced that its collaborator Pennington Biomedical Research Institute at Louisiana State University, with Principal Investigator Dr. Frank Greenway, MD, has received FDA approval to begin human clinical Phase I studies.